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ABSTRACT 
Anxiety contributes to the chest pain symptom complex in 30%-40% of patients with low 
risk chest pain seen in the Emergency Department (ED). The validated Hospital Anxiety 
Depression Scale – Anxiety subscale (HADS-A) has been used as an anxiety screening tool in 
this population. The objective was to determine the prevalence of abnormal HADS-A scores in a 
cohort of low-risk chest pain patients and test the association of HADS-A score with subsequent 
healthcare utilization and symptom recurrence. In a single-center, prospective, observational 
cohort study of adult ED subjects with low risk chest pain, the HADS-A was used to stratify 
participants into 2 groups: Low anxiety (score<8) and High anxiety (score≥8). At 45-day follow-
up, chest pain recurrence was assessed by patient report while ED utilization was assessed via 
chart review. Of the 167 subjects enrolled, 78 (47%) were stratified to high anxiety. The relative 
risk for high anxiety being associated with at least 1 30-day ED return visit was 2.6 (95% CI 1.4 
to 4.7) and this relative risk increased to 9.1 (95% CI 2.18 to 38.6) for 2 or more ED return visits. 
Occasional chest pain recurrence was reported by more subjects in the high anxiety group, 68% 
vs. 47% (p=0.029). In conclusion, 47% percent of low risk chest pain cohort had abnormal levels 
of anxiety. These patients were more likely to have occasional recurrence of their chest pain and 
had an increased risk multiple ED return visits.  
Key Words: Acute Coronary Syndrome, Psychological Conditions, Chest Pain, Anxiety, 
Emergency Department, Recidivism  
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INTRODUCTION 
Chest pain is 1 of the most common chief complaints evaluated by emergency practitioners.
1
 
However, the majority of visits are found to be low risk for cardiopulmonary emergencies 
including acute coronary syndromes after extensive emergency department (ED) evaluations.
2-4
  
Previous work has found that 25% - 50% of patients presenting with low-risk chest pain have 
moderate to severe anxiety which often remains undiagnosed in up to 90%.
5-9
 This is significant 
as undiagnosed and untreated anxiety has a negative impact on quality of life, worsens the 
patient’s perceptions of wellness5,10, and ironically contributes to systemic inflammation11, which 
is the underlying pathophysiology of coronary artery disease.
12,13
 The validated HEART score is 
a common acute coronary syndrome (ACS) risk-stratification tool for ED patients with chest 
pain; patients designated as low risk have a <2% risk of major adverse cardiac events (MACE) in 
30 days.
14
 Likewise, the validated Hospital Anxiety Depression Scale – Anxiety subscale 
(HADS-A) has been used as an anxiety screening tool in the ED chest pain population.
7,15
 We 
administered these tools sequentially in a population of patients with low risk chest pain with the 
objective of determining the prevalence of abnormal anxiety levels (HADS-A ≥8) in a cohort of 
low-risk chest pain patients and to provide preliminary estimates of the risk of increased 
healthcare utilization and symptom recurrence over the course of the subsequent 45 days 
associated with a HADS-A score ≥8. We hypothesized that the prevalence of subjects with 
HADS-A scores ≥8 would be 30% or greater and that these subjects would display greater ED 
utilization and chest pain symptom recurrence than subjects with HADS-A scores <8.  
METHODS 
 This was a single-center prospective observational cohort study of patients with low risk 
chest pain and symptoms of anxiety. This study was approved by the Indiana University School 
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of Medicine Institutional Review Board (protocol # 1602878994) and written informed consent 
was obtained from all participants. These results are reported in accordance with STROBE 
guidelines. Between June 2016 and June 2017, we prospectively collected data on patients 
presenting with chest pain to Indiana University Health Methodist Hospital, an urban emergency 
department. This academic center has an annual ED volume of approximately 105,000. Trained 
research assistants identified potential subjects using the electronic tracking board in the ED. 
Enrollment occurred Monday through Friday with coverage for 10 hours per day. Inclusion 
criteria consisted of adult patients (aged 18-70) presenting with a triage nurse-written chief 
complaint of “chest pain”.  These subjects were screened for ACS risk status using the validated 
HEART score. Low risk patients with a score less than 4 corresponding to < 2% risk of MACE 
were eligible for enrollment.
14
 ED faculty and residents provided this information to research 
assistants in real time. Exclusion criteria included a prior ACS history, traumatic injury, active 
psychosis or behavioral issues requiring psychiatric monitoring, hemodynamic instability, and 
potential issues affecting follow up (prisoners, homeless patients, out-of-town residences).  
Participating subjects signed a written informed consent statement. Using a standard case 
report form (available upon request) we collected a number of domains including demographics 
(age, gender, race, ethnicity, level of education, employment status as well as marital status), past 
medical history, symptom descriptions, healthcare utilization over the previous 12 months as 
well as stratification by the HADS-A, which was our primary variable of interest. The HADS 
depression subscale (HADS-D) was also collected. This information was obtained from both the 
patient and the electronic medical record (EMR). At 45 days, we followed these patients for 
outcomes through telephone contact, custom and validated questionnaires, and review of the 
EMR.  
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After enrollment, participants were stratified by level of anxiety as indicated by their 
score on the HADS-A. The population was split into 2 groups: 1 – normal or low anxiety levels 
(HADS-A score < 8) and 2 – abnormal or high anxiety levels (HADS-A score ≥ 8). The 
prevalence of abnormal anxiety (proportion of subjects stratified into group 2) was the primary 
outcome of this study. This score was calculated at both enrollment as well as 45-day follow up 
in order to determine whether the abnormal anxiety symptoms identified persist beyond the ED 
evaluation. The HADS is a prospectively validated self-report scale made of 14 items to screen 
for mood disorders in non-psychiatric outpatient settings. There are 2 subscales (anxiety and 
depression) consisting of 7 items each. The total score from each subscale ranges from 0-21 with 
scores ≥ 8 indicating borderline or abnormal anxiety/depression. This tool has been prospectively 
validated in the Emergency setting and has been found to be reliable with a Cronbach’s α=0.83 
indicating excellent internal consistency of the anxiety subscale.
7,15,16
 Both providers and patients 
were blinded to HADS-A scores. 
After stratification via the HEART score but before approach of low-risk patients, 
clinicians (faculty and residents) were presented with a 100-mm visual analog scale (VAS) and 
asked: “What is your level of suspicion that this patient’s chest pain is caused by stress or 
anxiety?” The physician was instructed to place a vertical mark on the line corresponding to their 
level of suspicion. These marks were measured in millimeters and directly converted to 
percentages. These clinicians were aware their assessment was being used for research purposes.  
At enrollment, patients were asked what they thought the cause of their chest pain was 
and answer choices included: 1. heart problems, 2. heartburn or stomach problems, 3. lung 
problems, 4. problems with the muscles or bones of chest wall, 5. stress/anxiety or 6. other cause. 
With regard to healthcare utilization, from the EMR, we documented the number of ED visits 
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regardless of reason in the previous 12 months as well as in the 30 days post enrollment. 
Additionally, we collected the patient’s ED disposition at their enrollment visit (discharge, 
overnight observation, admission) as well as up to 3 documented discharge diagnoses. Similarly, 
the EMR was reviewed for intervening 30-day ED returns, overnight observations, admissions 
and their disposition. At 45-day phone follow-up, patients were asked if they had recurrence of 
their chest pain, and if that recurrence was daily, occasionally/several times per week, or never. 
Based on prior work we estimated that approximately 30% of low risk chest pain patients 
would score ≥8 on the HADS-A, indicating abnormal anxiety.17 Thus, with a 95% confidence 
level and a 15% confidence interval width, the required sample size was estimated to be 154. 
Data were analyzed using STATA 14.2 (Stata Corp., College Station, Texas). T-tests were 
utilized to compare means for continuous outcome variables. Categorical outcome variables were 
assessed with chi-square or Fisher’s exact test as appropriate. At study inception, it was decided 
that the prevalence of anxiety would be equal to the proportion of subjects with a HADS-A score 
≥8. We used McNemar’s test to evaluate initial and follow-up HADS. We report the number of 
subjects with missing data for each outcome assessed and those subjects are not included in that 
particular analysis. The Indiana University – Purdue University Indianapolis Office of the Vice 
Chancellor for Research had no role in the study design, collection, analysis, or writing of this 
manuscript. Participants were eligible to receive a total of $80 for completion of the ED 
interview and as well as the follow-up questionnaires.  
RESULTS 
Four hundred forty-two patients were screened for enrollment (Figure 1). Of these, 80 
patients (18.1%) were not eligible due to a HEART score > 3 and thus not considered low risk, 
182 (41.4%) declined enrollment (demographics provided in appendix 1), 12 (2.7%) were 
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discharged prior to being approached for the study, and 5 (1.1%) were unable to complete the 
study tasks. Ultimately 163 (36.8%) subjects met enrollment criteria and gave informed consent. 
Demographics and ultimate disposition of enrolled subjects are presented in Table 1. Eighty-
seven (53%) had normal anxiety levels (Group 1) with a score <8 while the remaining 76 (47%) 
subjects (Group 2) had abnormal or high anxiety levels (HADS-A ≥ 8).  There were no 
statistically significant differences between patients stratified into these 2 groups based on age, 
gender, race, marital status, education, or employment status.  
ED provider VAS scores (gestalt) for the suspicion of anxiety correlated significantly 
with HADS-A scores (Spearman’s rho = 0.43, P<0.001).  Mean VAS scores were also 
significantly different and concordant with anxiety group stratification (low anxiety - 28% vs. 
high anxiety - 43%) as shown in Table 1. Overall, 58 subjects (39%) indicated a belief that their 
chest pain symptoms were caused by stress or anxiety at enrollment and 44/58 (76%) of these 
were in the high anxiety group (p<0.01). This belief regarding anxiety and symptoms remained 
significant at 45-day follow-up as 28/41 (68%) subjects who indicated they believed anxiety was 
the cause of their symptoms at follow-up were group 2 participants (Appendix 2).   
The clinician marked a ≥50% suspicion of anxiety on the VAS in 28 of the 58 patients 
(48%) who also indicated belief that stress or anxiety caused his or her chest pain. Clinicians also 
marked a ≥50% suspicion of anxiety in 34 (45%) high anxiety subjects compared to 20 (23%) 
stratified to low anxiety (p=0.005). Finally, there were 44 (58%) high anxiety subjects who 
ascribed their symptoms to anxiety and the clinician also marked ≥50% suspicion of anxiety in 
22 patients (50%)  in this group (p=0.008) with a kappa statistic 0.21 (95% CI= 0.06 to 0.37).  
The HADS-A was again assessed at follow-up and the majority of subjects in each group 
maintained their group classification – group 1 (73%) and group 2 (76%) (see Figure 2). This 
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change at follow-up assessment shown in figure 2 was not significantly different (McNemar’s 
Test, p-value 0.64).   
Comorbid depression, had an overall moderate positive correlation between HADS-A 
and HADS-D scores (Pearson’s R of 0.519). Abnormal depression scores were found in 30% of 
all subjects and 35 (45%) had both abnormal anxiety as well as depression. Mean depression 
scores were significantly higher in the high anxiety subgroup compared with the low anxiety 
subgroup (Difference = 3.64, 95% CI 2.17 to 5.10). 
Discharge diagnoses (primary through tertiary) were obtained for 162 patients. Primary 
diagnosis was categorized and examined by HADS-A score (Table 2). Chest pain NOS 
(including chest pain unspecified, chest pain, and other chest pain) was the primary discharge 
diagnosis for 69% of patients. Five subjects (3%) received an anxiety-related diagnosis at least 
secondarily and 4 of those were in group 2. Nineteen (14%) patients received a stress 
echocardiography, 10 (7%) received a nuclear stress test, and 3 (2%) underwent cardiac 
catheterization. The frequency of cardiac testing did not differ between groups. There were 2 
patients (1.2%) diagnosed with Acute Coronary syndrome, both of whom were in the low 
anxiety group and were admitted. A complete breakdown of specific primary diagnoses is shown 
in Appendix 3.   
To examine the potential cause and effect relationship between anxiety and recurrent ED 
use, we measured ED visits both retrospectively and prospectively. Figure 3a shows the 
distribution of return ED visits in the 12 months prior to enrollment. Among 306 visits to the ED 
in the 12 months prior to enrollment, 191 (62%) came from subjects with high anxiety. ED 
utilization was significantly different and concordant with group stratification when looking at 
the 105 subjects that had at least 1 ED visit during that time period. Fifty-two percent of subjects 
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(45/87) in the low anxiety group had at least 1 ED visit during the previous 12 months compared 
with 79% (60/76) in the high anxiety group for a proportional difference of 27% (95% CI for 
difference -0.41 to -0.13).   
Regarding ED recidivism after enrollment, overall, there were 72 return ED visits within 
30 days, 56 (78%) of which were in the high anxiety group (p=0.001) (Figure 3b). The relative 
risk for anxiety being associated with at least 1 30-day ED return visit was 2.6 (95% CI 1.4 to 
4.7) and this relative risk increased to 9.1 (95% CI 2.2 to 38.6) for 2 or more ED return visits. 
There was no difference in 30-day observation stays or admissions between groups (Figures 3c 
and 3d). At 45-day follow-up, 109 subjects provided information about the recurrence of their 
chest pain as described above. We analyzed the provided answers by anxiety group stratification 
comparing no recurrence versus at least occasional recurrence. Overall, 58% of the cohort 
reported at least occasional recurrence of their chest pain (Figure 4). Twenty-five low anxiety 
subjects (47%) had recurrent chest pain compared to 38 (68%) of high anxiety subjects for a 
difference of 21% (95% CI for difference 0.01 to 0.41). Three subjects reported daily recurrence 
and were in the low anxiety group.  
DISCUSSION 
 This work focuses on quantifying the importance of psychosomatic contributors such as 
panic or anxiety disorders to the chest pain symptom complex, a constellation of measureable 
and unmeasurable factors which manifest in varying degrees of intensity and is defined by 
angina-like pain in the absence of coronary stenosis.
8,9,18,19
 Measureable factors include the 
perception of pain, fear, anxiety, and patient desire for an explanation of the problem. Currently 
unmeasured factors include the influence of anxiety as a symptom amplifier, coping skills, 
personality traits, and the future risk of cardiac injury, either from undetected coronary stenosis, 
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microvascular ischemia, or progression of atherosclerosis. We believe this study represents the 
first use of the specific 2-step screening process (HEART score + HADS-A) to identify low-risk 
chest pain subjects with abnormal anxiety as part of their chest pain symptom complex. The 
main message of this work is that in this cohort of low-risk chest pain subjects, the prevalence of 
abnormal anxiety symptoms was 47% and this was associated with a high rate of ED recidivism 
and a low rate of medical diagnoses.   
 The prevalence of anxiety found in this population (47%) is higher than recent work done 
by Al-Ani et al, who showed the prevalence of anxiety in their low risk population to be 30%.
20
 
However, it is quite consistent with the literature at large taking into account a systematic review 
by Webster et al, which incorporated 9 studies and found the prevalence to be between 21 and 
58%.
21
 We asked providers to rate their suspicion (gestalt) of current anxiety on the presenting 
chest pain, whereas the HADS-A asks about anxiety symptoms over the past 2 weeks. Without 
the benefit of the HADS-A results, provider gestalt correlated significantly with those values, as 
mean provider VAS scores for the suspicion of anxiety was significantly higher in the group 
stratified to have abnormal anxiety levels. Surprisingly, subjects also self-identified anxiety as 
the cause for their symptoms at rates that were concordant with their anxiety group classification. 
A striking observation is that over half the individuals in the high anxiety group (58%) ascribed 
their chest pain symptoms to anxiety when asked and given a list of possible causes. This is 
much higher than the 8% of patients who self-identified anxiety as likely the cause for their chest 
pain symptoms as assessed via an open-ended question at follow-up regarding the perceived 
cause of their chest pain.
22
 This is quite interesting as the individuals in our study made this 
determination while they were still in the ED undergoing current evaluation of their chest pain. 
Reliable self-report has been identified as a key feature of future DSM-V anxiety disorder.
23,24
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The fact that subjects were willing to disclose this thought process while still undergoing 
evaluation demonstrates self-awareness and may indicate that simply asking patients what they 
attribute their symptoms to yields valuable information in this population.  
Our data allow the hypothesis that patient anxiety may drive them towards low value 
healthcare utilization. The rates of ED use were 2-fold higher in patients with HADS-A scores 
≥8 both before and after enrollment, and these differences were not explained by illness acuity or 
medical diagnoses. Additionally, three-quarters of the enrolled population had persistent, 
problematic levels of anxiety at follow up, suggesting more than a “white coat” phenomenon. It 
is unclear if these subjects had generalized anxiety or specifically cardiac related hypervigilance 
leading to anticipatory anxiety when experiencing sensations associated with their chest pain.  
The latter can also be classified as interoceptive fear conditioning which has been shown to be 
associated with high longitudinal healthcare utilization despite the chest pain symptoms over 
time.
25
  Additionally, abnormal anxiety and interoceptive symptomatology are associated with 
increased vigilance and fear of cardiopulmonary sensations.
26,27
  It may be possible that the 
development of anxiety or “post-traumatic” stress response described in patients after life 
threatening events like ACS may also affect predisposed individuals after cardiac evaluation.
28
 In 
any case, there is strong evidence showing that low risk or non-cardiac chest pain associated with 
anxiety and other psychological comorbidities are associated with more frequent medical visits 
than community norms.
25,29
 It appears that normal test results and reassurance are not enough to 
allay the residual anxiety and persistent belief in a cardiac cause of their chest pain 
symptoms.
21,30
 We suspect these subjects are at risk of falling into a cycle with contributory 
learned responses of unexplained chest pain, anxiety, and health seeking behavior.  
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 The primary limitation of this work is that the presence of anxiety symptoms was 
assessed using a screening tool, the Hospital Anxiety Depression Scale, but subjects did not 
undergo a formal diagnostic psychiatric evaluation using accepted tools such as the Structured 
Clinical Interview for DSM Disorders (SCID). However, as a practical consideration, a formal 
evaluation would rarely occur in the ED and that some combination of provider gestalt + anxiety 
symptom severity screening tool and/or patient self-report is probably sufficient to initiate 
referral for further anxiety evaluation. Further, the HADS-A has been shown to perform well as a 
screening tool assessing symptom severity and a case-finder for anxiety when the appropriate 
cutoffs are used.
16
 Secondly, this was a convenience sample of subjects at a single hospital site 
and does not account for the patient population who would have presented either on nights or 
weekends, which may have had different characteristics. Additionally, follow up chart review 
was limited to a single hospital system which may have missed recurrent visits to other hospitals 
not within the system. ED visits were also included regardless of reason for visit thus not all may 
have been due to chest pain. However, it is informative that the number of visits were 
significantly different when stratified by anxiety symptom severity. Chest pain recurrence is 
quite subjective and prone to recall bias especially given the 6-week period of time we assessed.  
 Using a simple 2-step screening process in chest pain patients in the ED we identified a 
subpopulation with abnormal and largely persistent anxiety symptoms with a high rate of ED 
recidivism and recurrent symptoms. Thus, despite the primary imperative of an ED provider to 
identify threats to life, we posit that early identification using a screening process such as this in 
addition to appropriate referral may break this cycle and affect the trajectory of their care. To 
ensure generalizability, next steps should include confirmation of these outcomes in a larger 
cohort of patients with different sociodemographic characteristics at multiple sites. 
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Appendix 1 
Demographics of participants who declined enrollment. 
Variable Patients who declined enrollment 
Age, mean (SD) 47.8 ± 10.6 
Female 
Male 
105 (59%) 
74 (41%) 
African American 
White 
Asian 
Hispanic 
Other 
81 (46%) 
90 (51%) 
  1 (0.6%) 
  5 (2.8%) 
  1 (0.6%) 
Provider suspicion of 
anxiety VAS, mean 
(95% CI) 
34 (30, 38) 
Disposition 
Admit inpatient 
Admit observation 
Discharged 
Left AMA 
 
  9 (5%) 
17 (10%) 
149 (85%) 
  0 (0%) 
 
Appendix 2 
Patient belief regarding cause of chest pain at 45-day follow-up 
Variable All patients Group 1 HADS-A 
score < 8 
Group 2 HADS-A 
score ≥ 8 
P-value 
Stress or anxiety* 
Non-stress or anxiety* 
Heart 
Lung  
Heartburn/Stomach  
Muscles or bones 
Other 
41 (38%) 
68 (62%) 
15 (14%) 
6 (6%) 
15 (14%) 
11 (10%) 
21 (19%) 
13 (25%) 
40 (75%) 
  8 (15%) 
2 (4%) 
12 (23%) 
 6 (11%) 
12 (23%) 
28 (50%) 
28 (50%) 
  7 (13%) 
4 (7%) 
3 (5%) 
5 (9%) 
  9 (16%) 
0.006 
*Groups compared for test of significance  
 
Appendix 3 
Full primary discharge diagnosis by group 
Diagnosis All patients Group 1 HADS-A 
score < 8 
Group 2 HADS-A 
score ≥ 8 
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Abdominal pain 
Angina 
Anorexia 
Arm pain 
Atherosclerotic heart disease 
Bronchitis 
Chest pain 
Chest pain, non-cardiac 
Chest pain, unspecified 
Chostochondritis 
Chronic obstructive pulmonary disease 
Epigastric pain 
Fatigue 
Gastro-esophageal reflux disease 
Generalized hyperhidrosis 
Headache 
Hypertension 
Intestinal obstruction 
Low back pain 
Nausea and vomiting 
Non-pressure chronic ulcer 
Other chest pain 
Other specified anxiety 
Pericarditis 
Pleurodynia 
Precordial pain 
Premature depolarization 
Respiratory failure 
Shortness of breath 
Thoracic aortic ectasia 
1 (0.6%) 
1 (0.6%) 
1 (0.6%) 
1 (0.6%) 
1 (0.6%) 
1 (0.6%) 
40 (26%) 
2 (1%) 
46 (28%) 
2 (1%) 
2 (1%) 
1 (0.6%) 
1 (0.6%) 
1 (0.6%) 
1 (0.6%) 
1 (0.6%) 
4 (3%) 
1 (0.6%) 
1 (0.6%) 
1 (0.6%) 
1 (0.6%) 
24 (15%) 
1 (0.6%) 
1 (0.6%) 
1 (0.6%) 
17 (11%) 
1 (0.6%) 
1 (0.6%) 
4 (3%) 
1 (0.6%) 
1 (1%) 
1 (1%) 
0 (0%) 
1 (1%) 
1 (1%) 
1 (1%) 
20 (23%) 
1 (1%) 
29 (33%) 
1 (1%) 
1 (1%) 
1 (1%) 
0 (0%) 
1 (1%) 
0 (0%) 
0 (0%) 
2 (2%) 
1 (1%) 
1 (1%) 
0 (0%) 
1 (1%) 
7 (8%) 
0 (0%) 
1 (1%) 
1 (1%) 
11 (13%) 
1 (1%) 
0 (0%) 
2 (2%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (1%) 
0 (0%) 
0 (0%) 
0 (0%) 
20 (27%) 
1 (1%) 
17 (23%) 
1 (1%) 
1 (1%) 
0 (0%) 
1 (1%) 
0 (0%) 
1 (1%) 
1 (1%) 
2 (3%) 
0 (0%) 
0 (0%) 
1 (1%) 
0 (0%) 
17 (23%) 
1 (1%) 
0 (0%) 
0 (0%) 
6 (8%) 
0 (0%) 
1 (1%) 
2 (3%) 
1 (1%) 
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Figure 1: Flow Diagram of Enrollment. Shows number of subject screened, excluded and 
ultimately enrolled. Additionally, provides number of participants included in each outcome 
analyzed.  
Abbreviations: emergency department (ED), hospital anxiety depression scale-anxiety subscale 
(HADS-A), visual analog scale (VAS). 
 
Figure 2: Anxiety level at 45-day follow-up compared to baseline.  
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Figure 3a: ED visits in the past twelve months 
 
Figure 3b: Return visits to the ED within 30 days. 
 
Figure 3c: Number of return visits resulting in an observation admission within 30 days. 
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Figure 3d: Number of return visits resulting in an inpatient admission within 30 days. 
 
Figure 4: Recurrence of chest pain episodes assessed at 45-day follow-up.  
 
Table 1 
Demographics and provider visual analog scale for anxiety suspicion versus patient perception of chest pain cause  
Variable All patients 
Group 1 HADS-A 
score < 8 
Group 2 HADS-A score ≥ 
8 
P-value 
Age, mean (SD) 47.4 ± 10.8 48.6 ± 10.6 46.0 ± 10.8 0.13* 
Female 
Male 
111 (68%) 
52 (32%) 
56 (64%) 
31 (36%) 
55 (72%) 
21 (28%) 
0.27 
Black 
White 
Asian 
Hispanic 
84 (52%) 
74 (45%) 
  2 (1%) 
  3 (2%) 
44 (51%) 
40 (46%) 
  1 (1%) 
  2 (2%) 
40 (53%) 
34 (45%) 
  1 (1%) 
  1 (1%) 
0.97 
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Marital status
a
 
Divorced 
Married 
Separated 
Single 
Widowed 
 
27 (18%) 
47 (32%) 
  7 (5%) 
63 (43%) 
  4 (3%) 
 
14 (19%) 
25 (34%) 
  2 (3%) 
31 (43%) 
  1 (1%) 
 
13 (17%) 
22 (29%) 
  5 (7%) 
32 (43%) 
  3 (4%) 
0.64 
Education
a
 
General Equivalency 
Diploma 
Graduate/professional 
Graduated college 
High School 
Some college 
Some high school 
 
  6 (4%) 
 
  8 (5%) 
30 (20%) 
41 (28%) 
43 (29%) 
20 (14%) 
 
  1 (1%) 
 
  4 (6%) 
19 (26%) 
21 (29%) 
21 (29%) 
  7 (10%) 
 
  5 (7%) 
 
  4 (5%) 
11 (15%) 
20 (27%) 
22 (29%) 
13 (17%) 
0.25 
Employment
a
 
Disabled 
Full-time 
Part-time 
Retired 
Student, not working 
Student and working 
Unemployed 
 
18 (12%) 
88 (60%) 
16 (11%) 
  6 (4%) 
  1 (1%) 
  1 (1%) 
18 (12%) 
 
  5 (7%) 
48 (66%) 
8 (11%) 
  5 (7%) 
  0 (0%) 
  0 (0%) 
  7 (10%) 
 
13 (17%) 
40 (53%) 
8 (11%) 
  1 (1%) 
  1 (1%) 
  1 (1%) 
11 (15%) 
0.13 
Disposition 
Admit inpatient 
Admit observation 
Discharged 
Left Against medical advice 
 
 13 (8%) 
 15 (9%) 
132 (81%) 
   3 (2%) 
 
  6 (7%) 
11 (13%) 
68 (78%) 
  2 (2%) 
 
  7 (9%) 
  4 (5%) 
64 (84%) 
  1 (1%) 
0.38 
Provider suspicion of 
anxiety - Visual Analog 
Scale, mean (95% CI) 
34.9 (30.5,39.3) 27.9 (22.8, 33.0) 43.0 (36.1, 49.9) <0.001* 
Patient belief regarding 
cause of chest pain 
Stress or anxiety** 
Non-stress or anxiety** 
Heart 
Lung  
Heartburn/Stomach  
Muscles or bones 
Other 
 
 
58 (39%) 
90 (61%) 
29 (20%) 
10 (7%) 
12 (1%) 
11 (7%) 
28 (19%) 
 
 
14 (19%) 
59 (81%) 
18 (25%) 
  6 (8%) 
  9 (12%) 
  8 (11%) 
18 (25%) 
 
 
 
44 (59%) 
31 (41%) 
11 (15%) 
  4 (5%) 
  3 (4%) 
  3 (4%) 
10 (13%) 
 
<0.01 
a
Missing values for 15 patients 
*T-test 
**Groups compared for test of significance 
 
 
Table 2 
Primary discharge diagnoses 
Diagnosis All patients Group 1 HADS-A 
score < 8 
Group 2 HADS-A 
score ≥ 8 
P-value 
Anxiety related diagnoses Total 
Primary 
Secondary 
 
5 
1 
4 
 
1 
0 
1 
 
4 
1 
3 
0.13 
Final diagnosis by category    0.67 
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Angina 
Coronary artery disease 
Chest pain 
Hypertension 
Other 
Respiratory 
 1 (1%) 
 1 (1%) 
112 (69%) 
 4 (3%) 
15 (9%) 
  28 (17%) 
1 (1%) 
1 (1%) 
57 (66%) 
2 (2%) 
  9 (10%) 
17 (20%) 
0 (0%) 
0 (0%) 
55 (73%) 
2 (3%) 
6 (8%) 
11 (15%) 
 
 
 
